Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Nov
16
2023
October 2023 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Nov
16
2023
Recent Federal Developments - November, 2023 Bergeson & Campbell, P.C.
Nov
15
2023
Florida Proposes New Pharmacy Benefit Manager Rules Polsinelli PC
Nov
15
2023
Third Time’s A Charm: California Re-Introduces Proposed Changes to Proposition 65’s Warnings and Safe Harbor Requirements ArentFox Schiff LLP
Nov
15
2023
This Week in 340B: November 6 – 12, 2023 McDermott Will & Emery
Nov
15
2023
Proactive Strategies in IPRs after Allgenesis Squire Patton Boggs (US) LLP
Nov
15
2023
Ozempic Gains Popularity, Its Maker Loses First Legal Fight Proskauer Rose LLP
Nov
15
2023
NYC Council Passed Bill to Require Added Sugar Icons for Chain Restaurant Menu Items Keller and Heckman LLP
Nov
14
2023
EPA Seeks Comment on Its Sweeping Proposal to Ban Manufacture and Commercial and Industrial Use of Trichloroethylene (TCE) Foley & Lardner LLP
Nov
14
2023
Get Up, Stand Up: Mississippi Medical Cannabis Dispensary Sues State Challenging Advertising and Marketing Restrictions on First Amendment Grounds Bradley Arant Boult Cummings LLP
Nov
14
2023
Scope of Issued Patents May be Limited by Prosecution Estoppel Created in Child Cases Proskauer Rose LLP
Nov
14
2023
Updates to Mexico’s Front of Pack Label Warnings Keller and Heckman LLP
Nov
14
2023
State AGs Demand Action on Pulse Oximeter Inaccuracy as FDA's Efforts Lag Mintz
Nov
14
2023
HHS-HRSA Terminates 340B Drug Pricing Program Registration Waiver Barnes & Thornburg LLP
Nov
14
2023
USDA, EPA, and FDA Post Report on Stakeholder Comments on Coordinated Framework for the Regulation of Biotechnology and Plain-Language Regulatory Information Bergeson & Campbell, P.C.
Nov
14
2023
FDA Delays Enforcement of Cosmetic Facility Registration and Product Listing Requirements ArentFox Schiff LLP
Nov
13
2023
California Restaurants Must Reimburse Employees for Food Handling Certifications Barnes & Thornburg LLP
Nov
13
2023
Maine Disclosure Requirements Burden Industry Members McDermott Will & Emery
Nov
13
2023
Nature May Abhor a Vacuum But North Carolina Has Learned the Same Isn't True of Europeans with PFAS They Don't Want Mintz
Nov
13
2023
FDA Delays Enforcement of MoCRA Facility Registration and Cosmetic Product Listing Requirements Mintz
Nov
13
2023
CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule Sheppard, Mullin, Richter & Hampton LLP
Nov
13
2023
Petition for USDA-FDA Dual Jurisdiction on Eggs Denied Keller and Heckman LLP
Nov
13
2023
Defra Publishes Policy Paper on UK REACH Alternative Transitional Registration Model Bergeson & Campbell, P.C.
Nov
13
2023
PFAS State AG Lawsuits Update: Delaware Enters the Fray CMBG3 Law
Nov
13
2023
A Look at FDA’s Proposed Changes to Labeling for Biosimilars and Interchangeable Biosimilars Foley & Lardner LLP
Nov
10
2023
DC Circuit Vacates MDO for Tobacco-Flavored myblu ENDS Products; Potential Impact on Pending Juul PMTA Keller and Heckman LLP
Nov
10
2023
Biden Administration Announces Toolkit For “Recovery Ready Workplaces” Jackson Lewis P.C.
Nov
10
2023
Issue 2: What Legalized Recreational Marijuana Use Means for Ohio Employers Dinsmore & Shohl LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins